AM
Therapeutic Areas
Cytoki Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CK-0045 | Obesity and Type 2 Diabetes | Phase 2 |
Leadership Team at Cytoki Pharma
RJ
Rasmus Jorgensen
CEO & Founder
AL
Anne Louise Kjølbye
Chief Development Officer
MV
Martijn van de Bunt
Chief Scientific Officer
DW
Dorte Waaben
Head of CMC
KS
Karsten Skydsgaard
Head of Non-Clinical Development
CF
Christian Friis
Clinical Project Leader